Vlad-Florin Oiegar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vlad-Florin Oiegar has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Paraschiva Postolache
Department of Biomedical Sciences, Faculty of Medical Bioengineering, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iași, Romania; 10. Academy of Romanian Scientists, 3 Ilfov Street, 050044 Bucharest, Romania, Iasi, Romania, Romania
5 shared publications - Constantin Ghimus
Doctoral School, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
3 shared publications Catalina-Florina Oiegar
2 shared publicationsConstantin Ghimus
2 shared publicationsConstantin Ghimuș
2 shared publicationsParaschiva Postolache
2 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (4) , 443
The Impact of Pulmonary Rehabilitation in Patients with Post-COVID-19 Syndrome: A Systematic Review
Background: Post-COVID-19 syndrome represents a global health problem, manifesting with persistent multiple organ symptoms, including respiratory ones. This review aimed to evaluate the efficacy of different pulmonary rehabilitation interventions in the management of the disease, including its particularities. Methods: This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) statement and prospectively registered in the PROSPERO database (CRD420261292824). PubMed, Embase, and the Cochrane Central Register of Controlled Trials were searched from January 2021 to January 2026. Two reviewers independently screened studies, extracted data, and assessed methodological quality using the Cochrane Risk of Bias 2 (RoB 2) tool. Twenty randomized controlled trials involving 2101 adult patients with post-COVID-19 syndrome met the eligibility criteria and were included in the qualitative synthesis. Results: Pulmonary rehabilitation (PR) demonstrated significant improvements in exercise capacity, with notable increases in 6MWT and VO2max. Respiratory and peripheral muscle strength significantly increased. The quality of life, dyspnea and fatigue consistently improved. The results for intrinsic pulmonary function, anxiety, and depression were heterogeneous, suggesting benefits more related to reconditioning. Conclusions: Pulmonary rehabilitation is an essential and efficient component in post-COVID-19 syndrome, improving physical function, respiratory and peripheral muscle strength, the quality of life, fatigue and dyspnea. Telerehabilitation is a viable alternative. Adapting protocols is crucial, recognizing that most benefits derive from physical reconditioning and muscle training, not necessarily from major structural pulmonary changes.
- 27 July 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (4) , 443
Open AccessThe Impact of Pulmonary Rehabilitation in Patients with Post-COVID-19 Syndrome: A Systematic Review
Background: Post-COVID-19 syndrome represents a global health problem, manifesting with persistent multiple organ symptoms, including respiratory ones. This review aimed to evaluate the efficacy of different pulmonary rehabilitation interventions in the management of the disease, including its particularities. Methods: This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) statement and prospectively registered in the PROSPERO database (CRD420261292824). PubMed, Embase, and the Cochrane Central Register of Controlled Trials were searched from January 2021 to January 2026. Two reviewers independently screened studies, extracted data, and assessed methodological quality using the Cochrane Risk of Bias 2 (RoB 2) tool. Twenty randomized controlled trials involving 2101 adult patients with post-COVID-19 syndrome met the eligibility criteria and were included in the qualitative synthesis. Results: Pulmonary rehabilitation (PR) demonstrated significant improvements in exercise capacity, with notable increases in 6MWT and VO2max. Respiratory and peripheral muscle strength significantly increased. The quality of life, dyspnea and fatigue consistently improved. The results for intrinsic pulmonary function, anxiety, and depression were heterogeneous, suggesting benefits more related to reconditioning. Conclusions: Pulmonary rehabilitation is an essential and efficient component in post-COVID-19 syndrome, improving physical function, respiratory and peripheral muscle strength, the quality of life, fatigue and dyspnea. Telerehabilitation is a viable alternative. Adapting protocols is crucial, recognizing that most benefits derive from physical reconditioning and muscle training, not necessarily from major structural pulmonary changes.
- Open Access
- 10 February 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (1) , 76
Multimodal Autoencoder–Based Anomaly Detection Reveals Clinical–Radiologic Heterogeneity in Pulmonary Fibrosis
Background: Pulmonary fibrosis (PF) and post-infectious fibrotic lung disease are characterized by marked heterogeneity in radiologic patterns, physiologic impairment, and clinical presentation. Conventional analytic approaches often fail to capture non-linear and multimodal relationships between structural imaging findings and functional limitation. Integrating imaging-derived representations with clinical and functional data using artificial intelligence (AI) may provide a more comprehensive characterization of disease heterogeneity. Objectives: The objective of this study was to develop and evaluate a multimodal AI framework combining imaging-derived embeddings and structured clinical data to identify atypical clinical–radiologic profiles in patients with pulmonary fibrosis using unsupervised anomaly detection. Methods: A retrospective cohort of 41 patients with radiologically confirmed pulmonary fibrosis or post-infectious fibrotic lung disease was analyzed. Deep imaging embeddings were extracted from baseline thoracic CT examinations using a pretrained convolutional neural network and integrated with standardized clinical and functional variables. A multimodal variational autoencoder (VAE) was trained in an unsupervised manner to learn the distribution of typical patient profiles. Patient-specific anomaly scores were derived from reconstruction error plus latent regularization (β·KL divergence). Associations between anomaly scores, disease severity, and clinical markers were assessed using Spearman rank correlation. Results: Anomaly scores were right-skewed (median 26.91, IQR 22.87–32.11; range 19.75–46.18). Patients above the 85th percentile (anomaly score ≥ 33.85) comprised 7/41 (17.1%) of the cohort and occurred across all clinician-assigned severity categories (mild 3, moderate 1, severe 3). Anomaly scores overlapped substantially across severity groups, with similar medians (mild 26.47, moderate 28.55, severe 28.23). Correlations with conventional severity markers were weak and non-significant, including DLCO (% predicted; ρ = −0.25, p = 0.115) and FEV1 (% predicted; ρ = −0.22, p = 0.165), a pattern consistent with anomaly scores reflecting multimodal deviation rather than severity alone, while acknowledging the exploratory nature of the analysis. Highly anomalous patients frequently exhibited discordant clinical–radiologic profiles, including preserved functional capacity despite marked imaging-derived deviation or disproportionate physiological impairment relative to imaging patterns. Conclusions: This proof-of-concept study demonstrates that multimodal VAE-based anomaly detection integrating imaging-derived embeddings with clinical data can quantify clinical–radiologic heterogeneity in pulmonary fibrosis beyond conventional severity stratification. Unsupervised anomaly detection provides a complementary framework for identifying atypical multimodal profiles and supporting individualized phenotyping and hypothesis generation in fibrotic lung disease. Given the modest cohort size, these findings should be interpreted as illustrative and hypothesis-generating rather than generalizable.
- 10 February 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (1) , 76
Open AccessMultimodal Autoencoder–Based Anomaly Detection Reveals Clinical–Radiologic Heterogeneity in Pulmonary Fibrosis
Background: Pulmonary fibrosis (PF) and post-infectious fibrotic lung disease are characterized by marked heterogeneity in radiologic patterns, physiologic impairment, and clinical presentation. Conventional analytic approaches often fail to capture non-linear and multimodal relationships between structural imaging findings and functional limitation. Integrating imaging-derived representations with clinical and functional data using artificial intelligence (AI) may provide a more comprehensive characterization of disease heterogeneity. Objectives: The objective of this study was to develop and evaluate a multimodal AI framework combining imaging-derived embeddings and structured clinical data to identify atypical clinical–radiologic profiles in patients with pulmonary fibrosis using unsupervised anomaly detection. Methods: A retrospective cohort of 41 patients with radiologically confirmed pulmonary fibrosis or post-infectious fibrotic lung disease was analyzed. Deep imaging embeddings were extracted from baseline thoracic CT examinations using a pretrained convolutional neural network and integrated with standardized clinical and functional variables. A multimodal variational autoencoder (VAE) was trained in an unsupervised manner to learn the distribution of typical patient profiles. Patient-specific anomaly scores were derived from reconstruction error plus latent regularization (β·KL divergence). Associations between anomaly scores, disease severity, and clinical markers were assessed using Spearman rank correlation. Results: Anomaly scores were right-skewed (median 26.91, IQR 22.87–32.11; range 19.75–46.18). Patients above the 85th percentile (anomaly score ≥ 33.85) comprised 7/41 (17.1%) of the cohort and occurred across all clinician-assigned severity categories (mild 3, moderate 1, severe 3). Anomaly scores overlapped substantially across severity groups, with similar medians (mild 26.47, moderate 28.55, severe 28.23). Correlations with conventional severity markers were weak and non-significant, including DLCO (% predicted; ρ = −0.25, p = 0.115) and FEV1 (% predicted; ρ = −0.22, p = 0.165), a pattern consistent with anomaly scores reflecting multimodal deviation rather than severity alone, while acknowledging the exploratory nature of the analysis. Highly anomalous patients frequently exhibited discordant clinical–radiologic profiles, including preserved functional capacity despite marked imaging-derived deviation or disproportionate physiological impairment relative to imaging patterns. Conclusions: This proof-of-concept study demonstrates that multimodal VAE-based anomaly detection integrating imaging-derived embeddings with clinical data can quantify clinical–radiologic heterogeneity in pulmonary fibrosis beyond conventional severity stratification. Unsupervised anomaly detection provides a complementary framework for identifying atypical multimodal profiles and supporting individualized phenotyping and hypothesis generation in fibrotic lung disease. Given the modest cohort size, these findings should be interpreted as illustrative and hypothesis-generating rather than generalizable.
- 1 November 2025
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences"
- No. 3(83),p. 237-244
Respiratory recovery in post-COVID-19 syndrome
Post-COVID-19 syndrome represents a complex clinical entity characterized by the persistence of symptoms for at least two months after the initial SARS-CoV-2 infection. This multisystemic condition involves respiratory, cardiovascular, neurological, and psychological dysfunctions, generating a significant impact on patients' quality of life. The present article examines the pathogenic mechanisms involved, including immune dysregulation, viral persistence, intestinal dysbiosis, and endothelial dysfunction. Diagnostic modalities and symptom severity assessment are also presented, with emphasis on the importance of respiratory function tests, exercise capacity evaluation, and quality of life assessment. Pulmonary rehabilitation, as the cornerstone in the management of post-COVID-19 syndrome, is detailed, highlighting the role of physical training, breathing techniques, and multidisciplinary support. In addition, specific aspects of postCOVID-19 interstitial lung disease (PC-ILD) and related therapeutic strategies are discussed. The article highlights the need for an individualized approach and careful monitoring of patients to optimize outcomes and improve prognosis.
- 1 November 2025
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences"
- No. 3(83),p. 237-244
Respiratory recovery in post-COVID-19 syndrome
Post-COVID-19 syndrome represents a complex clinical entity characterized by the persistence of symptoms for at least two months after the initial SARS-CoV-2 infection. This multisystemic condition involves respiratory, cardiovascular, neurological, and psychological dysfunctions, generating a significant impact on patients' quality of life. The present article examines the pathogenic mechanisms involved, including immune dysregulation, viral persistence, intestinal dysbiosis, and endothelial dysfunction. Diagnostic modalities and symptom severity assessment are also presented, with emphasis on the importance of respiratory function tests, exercise capacity evaluation, and quality of life assessment. Pulmonary rehabilitation, as the cornerstone in the management of post-COVID-19 syndrome, is detailed, highlighting the role of physical training, breathing techniques, and multidisciplinary support. In addition, specific aspects of postCOVID-19 interstitial lung disease (PC-ILD) and related therapeutic strategies are discussed. The article highlights the need for an individualized approach and careful monitoring of patients to optimize outcomes and improve prognosis.
- 30 May 2025
- Published by Editura Academiei Române in Romanian Journal of Medical Rehabilitation Physical Medicine and Balneoclimatology
- Vol. 2 (1) , 5-7
REFERENCE PILLAR IN PULMONARY REHABILITATION: IAȘI
Integrated pulmonary rehabilitation (PR) is crucial for managing chronic respiratory conditions, significantly enhancing patients' quality of life. The 2023 guidelines from the American Thoracic Society (ATS) define pulmonary rehabilitation as a tailored intervention that includes exercise training, education, and self-management aimed at improving both physical and psychological health. The COVID-19 pandemic accelerated the use of telehealth solutions in COPD management, with studies indicating that telerehabilitation can produce outcomes comparable to in-person rehabilitation. Additionally, self-management interventions have been shown to improve quality of life and reduce hospital admissions. Since the 1970s, pulmonary rehabilitation has evolved, with leading centers like the Cardiopulmonary Rehabilitation Clinic in Iași, Romania significantly influencing patient care and education. The Respiratory Rehabilitation Clinic at Rehabilitation Clinical Hospital from Iași currently implements comprehensive rehabilitation programs, focusing on ongoing assessment and coordination among healthcare professionals to optimize treatment plans and enhance patient outcomes in respiratory health.
- 30 May 2025
- Published by Editura Academiei Române in Romanian Journal of Medical Rehabilitation Physical Medicine and Balneoclimatology
- Vol. 2 (1) , 5-7
REFERENCE PILLAR IN PULMONARY REHABILITATION: IAȘI
Integrated pulmonary rehabilitation (PR) is crucial for managing chronic respiratory conditions, significantly enhancing patients' quality of life. The 2023 guidelines from the American Thoracic Society (ATS) define pulmonary rehabilitation as a tailored intervention that includes exercise training, education, and self-management aimed at improving both physical and psychological health. The COVID-19 pandemic accelerated the use of telehealth solutions in COPD management, with studies indicating that telerehabilitation can produce outcomes comparable to in-person rehabilitation. Additionally, self-management interventions have been shown to improve quality of life and reduce hospital admissions. Since the 1970s, pulmonary rehabilitation has evolved, with leading centers like the Cardiopulmonary Rehabilitation Clinic in Iași, Romania significantly influencing patient care and education. The Respiratory Rehabilitation Clinic at Rehabilitation Clinical Hospital from Iași currently implements comprehensive rehabilitation programs, focusing on ongoing assessment and coordination among healthcare professionals to optimize treatment plans and enhance patient outcomes in respiratory health.
- 15 February 2025
- Published by Editura Academiei Române in Romanian Journal of Medical Rehabilitation Physical Medicine and Balneoclimatology
- Vol. 1 (3) , 206-211
THE EVALUATION AND OPTIMISATION OF PACIENTS’ ADHERENCE TO PULMONARY REHABILITATION PROGRAMS
Rehabilitation programs for patients with chronic lung diseases are well-establiched as a means of enhancing standard therapy in order to control and alleviate symptoms and optimize functional capacity. Pulmonary rehabilitation is appropriate for any stable patient with a chronic lung diasease who is disabled by respiratory symptoms. Patient adherence in respiratory rehabilitation programs is crucial for the success of therapeutic interventions. Recent reports suggest that non-adherence can negatively affect clinical outcomes and patients' quality of life. This paper aims to analyze methods of evaluating adherence, identify factors influencing patient behavior, and propose effective strategies to enhance adherence. By adopting a multidisciplinary approach, the goal is to make a significant contribution to improving the conditions of patients requiring respiratory rehabilitation.
- 15 February 2025
- Published by Editura Academiei Române in Romanian Journal of Medical Rehabilitation Physical Medicine and Balneoclimatology
- Vol. 1 (3) , 206-211
THE EVALUATION AND OPTIMISATION OF PACIENTS’ ADHERENCE TO PULMONARY REHABILITATION PROGRAMS
Rehabilitation programs for patients with chronic lung diseases are well-establiched as a means of enhancing standard therapy in order to control and alleviate symptoms and optimize functional capacity. Pulmonary rehabilitation is appropriate for any stable patient with a chronic lung diasease who is disabled by respiratory symptoms. Patient adherence in respiratory rehabilitation programs is crucial for the success of therapeutic interventions. Recent reports suggest that non-adherence can negatively affect clinical outcomes and patients' quality of life. This paper aims to analyze methods of evaluating adherence, identify factors influencing patient behavior, and propose effective strategies to enhance adherence. By adopting a multidisciplinary approach, the goal is to make a significant contribution to improving the conditions of patients requiring respiratory rehabilitation.
- 1 January 2025
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences" in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
- Vol. 80 (3) , 172-178
Pulmonary rehabilitation in diffuse interstitial lung diseases: evidence and clinical applications
Diffuse interstitial lung diseases (ILD) are a heterogeneous group of diseases characterized by inflammation and fibrosis in the pulmonary interstitium, significantly affecting the gas exchange capacity and quality of life of patients. The most common forms of ILD include idiopathic pulmonary fibrosis (IPF), sarcoidosis, and interstitial pneumonias associated with autoimmune diseases, all of which have a considerable impact on respiratory function. The management of ILD is complex, including pharmacological treatments and non-pharmacological interventions, such as pulmonary rehabilitation (PR) programs, essential for the improvement of symptoms and quality of life. Pulmonary rehabilitation involves physical training, patient education, and psychosocial support, aiming to increase exercise tolerance and reduce symptoms. RR is tailored to the individual needs of patients, taking into account the severity of hypoxemia and associated comorbidities. Recent studies suggest that RR can have a significant positive impact on patients with ILD, even in advanced forms of the disease. Pulmonary rehabilitation programs are performed by multidisciplinary teams and require detailed assessments for appropriate adjustment of the exercises. The core component includes aerobic and strength exercises, adapted to prevent desaturation and excessive fatigue. Psychological support is also essential, given that patients frequently experience anxiety and depression. Through a personalized approach, pulmonary rehabilitation offers patients with ILD an effective way to manage symptoms, thereby improving residual lung function and quality of life. This intervention is becoming an integral part of the care of patients with progressive lung disease, with documented long-term benefits.
- 1 January 2025
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences" in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
- Vol. 80 (3) , 172-178
Pulmonary rehabilitation in diffuse interstitial lung diseases: evidence and clinical applications
Diffuse interstitial lung diseases (ILD) are a heterogeneous group of diseases characterized by inflammation and fibrosis in the pulmonary interstitium, significantly affecting the gas exchange capacity and quality of life of patients. The most common forms of ILD include idiopathic pulmonary fibrosis (IPF), sarcoidosis, and interstitial pneumonias associated with autoimmune diseases, all of which have a considerable impact on respiratory function. The management of ILD is complex, including pharmacological treatments and non-pharmacological interventions, such as pulmonary rehabilitation (PR) programs, essential for the improvement of symptoms and quality of life. Pulmonary rehabilitation involves physical training, patient education, and psychosocial support, aiming to increase exercise tolerance and reduce symptoms. RR is tailored to the individual needs of patients, taking into account the severity of hypoxemia and associated comorbidities. Recent studies suggest that RR can have a significant positive impact on patients with ILD, even in advanced forms of the disease. Pulmonary rehabilitation programs are performed by multidisciplinary teams and require detailed assessments for appropriate adjustment of the exercises. The core component includes aerobic and strength exercises, adapted to prevent desaturation and excessive fatigue. Psychological support is also essential, given that patients frequently experience anxiety and depression. Through a personalized approach, pulmonary rehabilitation offers patients with ILD an effective way to manage symptoms, thereby improving residual lung function and quality of life. This intervention is becoming an integral part of the care of patients with progressive lung disease, with documented long-term benefits.
- Open Access
- 1 December 2024
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences" in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
- Vol. 79 (2) , 215-223
Integrated pulmonary rehabilitation: multidisciplinary approaches and clinical outcomes in the management of chronic lung diseases
Integrated pulmonary rehabilitation (PR) is a fundamental pillar in the modern management of chronic lung diseases, aimed at significantly improving the quality of life and overall functionality of patients. According to the latest 2023 American Thoracic Society (ATS) guidelines, PR is defined as a multidimensional set of interventions designed to enhance the physical and psychosocial well-being of patients with chronic respiratory diseases through a personalized approach [1]. This rehabilitative model includes a broad spectrum of measures intended to reduce respiratory symptoms, increase exercise tolerance, and enhance patient autonomy within the context of a multidisciplinary team comprising pulmonologists, physiotherapists, nutritionists, psychologists, and social workers [2]. The origins of PR can be traced back to the 1960s, when physical training was the primary therapeutic strategy for patients with respiratory conditions. Over the decades, as the understanding of chronic lung diseases deepened, this concept evolved substantially, adding essential components such as psychological counseling, nutritional support, education, and social integration, all of which are now standard in treatment protocols [3]. The 2023 ATS guidelines emphasize the necessity of a holistic approach and underscore the central role of personalized rehabilitation programs to meet patients’ individual needs [4]. Physical training, focused on respiratory muscle rehabilitation and general endurance, remains the core of any PR program, with solid evidence supporting improvements in exercise capacity and reduction of dyspnea [5]. Patient education is also central, emphasizing symptom self-management, treatment adherence, and modification of risk behaviors [6]. Psychological support is crucial, given the high prevalence of depression and anxiety among patients with chronic lung diseases, while nutritional counseling contributes to maintaining homeostasis and muscle mass, essential for optimal pulmonary function [7]. Clinical studies highlight the positive outcomes of integrated PR on clinical and functional parameters, including significant reductions in dyspnea, increased exercise capacity, improved quality of life, and decreased hospitalization rates [2]. These benefits are also associated with a reduction in mortality rates, providing conclusive evidence for the importance of a multidisciplinary approach and personalized interventions [3]. In conclusion, integrated PR represents a comprehensive approach essential for optimizing the treatment of patients with chronic lung diseases, with a significant impact on clinical outcomes and quality of life.
- 1 December 2024
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences" in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
- Vol. 79 (2) , 215-223
Open AccessIntegrated pulmonary rehabilitation: multidisciplinary approaches and clinical outcomes in the management of chronic lung diseases
Integrated pulmonary rehabilitation (PR) is a fundamental pillar in the modern management of chronic lung diseases, aimed at significantly improving the quality of life and overall functionality of patients. According to the latest 2023 American Thoracic Society (ATS) guidelines, PR is defined as a multidimensional set of interventions designed to enhance the physical and psychosocial well-being of patients with chronic respiratory diseases through a personalized approach [1]. This rehabilitative model includes a broad spectrum of measures intended to reduce respiratory symptoms, increase exercise tolerance, and enhance patient autonomy within the context of a multidisciplinary team comprising pulmonologists, physiotherapists, nutritionists, psychologists, and social workers [2]. The origins of PR can be traced back to the 1960s, when physical training was the primary therapeutic strategy for patients with respiratory conditions. Over the decades, as the understanding of chronic lung diseases deepened, this concept evolved substantially, adding essential components such as psychological counseling, nutritional support, education, and social integration, all of which are now standard in treatment protocols [3]. The 2023 ATS guidelines emphasize the necessity of a holistic approach and underscore the central role of personalized rehabilitation programs to meet patients’ individual needs [4]. Physical training, focused on respiratory muscle rehabilitation and general endurance, remains the core of any PR program, with solid evidence supporting improvements in exercise capacity and reduction of dyspnea [5]. Patient education is also central, emphasizing symptom self-management, treatment adherence, and modification of risk behaviors [6]. Psychological support is crucial, given the high prevalence of depression and anxiety among patients with chronic lung diseases, while nutritional counseling contributes to maintaining homeostasis and muscle mass, essential for optimal pulmonary function [7]. Clinical studies highlight the positive outcomes of integrated PR on clinical and functional parameters, including significant reductions in dyspnea, increased exercise capacity, improved quality of life, and decreased hospitalization rates [2]. These benefits are also associated with a reduction in mortality rates, providing conclusive evidence for the importance of a multidisciplinary approach and personalized interventions [3]. In conclusion, integrated PR represents a comprehensive approach essential for optimizing the treatment of patients with chronic lung diseases, with a significant impact on clinical outcomes and quality of life.